OpenAlex
PricingAboutJobs
Log inGet started
Work

Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines

HTML

Year: 2013
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-12-2777
Authors: Floriana Morgillo, Ferdinando Carlo Sasso, Carminia Maria Della Corte, Donata Vitagliano, Elena D'Aiuto, Teresa Troiani, Erika Martinelli, Ferdinando De Vita, Michele Orditura, Raffaele De Palma, Fortunato Ciardiello
Institution: University of Campania "Luigi Vanvitelli"
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: metformin, gefitinib, non-small cell lung cancer, EGFR tyrosine kinase inhibitors, drug synergy, combination therapy, apoptosis, MAPK signaling, RAS/MAPK pathway, EGFR phosphorylation, drug resistance
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2152407075
FWCI: 8.971
Cites: 34
Cited by: 131
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security